Article
Molecular Pathogenesis of Gastrointestinal Stromal Tumor: A Paradigm for Personalized Medicine.
Annual review of pathology - 24 Jan 2022
Dermawan Josephine K, Rubin Brian P
Abstract excerpt
Over the past three to four decades, the molecular pathogenesis of gastrointestinal stromal tumors (GISTs) has been elucidated in great detail. In this review, we discuss the biological genesis of GISTs, identification of the various primary activating driver mutations (focusing on KIT and PDGFRA), oncogene addiction and targeted therapies with imatinib and other tyrosine kinase inhibitors, and the subsequent...
Topics
- Antineoplastic Agents
- Drug Resistance, Neoplasm
- Gastrointestinal Stromal Tumors
- Humans
- Mutation
- Precision Medicine
- Proto-Oncogene Proteins c-kit
- Receptor, Platelet-Derived Growth Factor alpha
